Navigation Links
Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
Date:10/22/2008

on an Adjusted Basis:

Cost of sales increased 1 percent to $590 million in the third quarter of

2008 versus $585 million in the third quarter of 2007. This increase was

due to higher sales volume offset by lower excess inventory write-offs,

lower excess capacity charges and lower cost ENBREL. The Company now

expects full year 2008 adjusted Cost of Sales expense as a percent of

sales to be approximately 15 percent.

Research & Development (R&D) expenses were relatively unchanged at $700

million in the third quarter of 2008 versus $699 million in the third

quarter of 2007. Higher staff-related costs as well as clinical trial

spend for our emerging pipeline were offset by lower clinical trial costs

for our denosumab registrational studies due to completion of enrollment

and the benefit derived from our licensing transaction with Takeda in

Japan. The Company now expects full year 2008 adjusted R&D expense

dollars to be slightly lower than 2007. Consistent with historical

spending patterns, the Company expects an increase in the fourth quarter

versus the third quarter that should be similar in magnitude to the

increase in 2007, though actual results may vary depending on licensing

activities and pipeline progress.

Selling, General & Administrative (SG&A) expenses increased 11 percent to

$890 million in the third quarter of 2008 versus $804 million in the

third quarter of 2007 reflecting higher Wyeth profit share expenses and

staff-related costs offset by lower litigation expense. Wyeth profit

share expenses increased 22 percent to $298 million in the third quarter

of 2008 versus $245 million in the third quarter of 2007. The Company

still expects Wyeth profit share to be one third of adjusted SG&A

expenses for the full year 2008. Excluding Wyeth profit share, adjusted

SG&A ex
'/>"/>

SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related biology technology :

1. CNS Response Announces Fiscal Third Quarter 2007 Results
2. Avitar Reports Third Quarter Financial Results for Fiscal 2007
3. Martek to Announce Third Quarter 2007 Results on September 5, 2007
4. Third Security, LLC Hires Two New Managing Directors
5. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
6. ThirdBiotech Networking Group Launches
7. BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends
8. PPD Announces Third Quarter 2007 Earnings Release, Webcast and Conference Call
9. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
10. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
11. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Md. , Dec. 24, 2014  United ... today that Medtronic, Inc. (NYSE: MDT ... the U.S. Food and Drug Administration (FDA) for ... implantable drug infusion system (including a newly developed ... (treprostinil) Injection delivered intravenously to patients with ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ... general corporate purposes. Under the terms ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by ... Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, End ... to 2019” provides a detailed overview of the ... and strategies impacting the preparative and process chromatography ... the revenue and share analysis. , Full ...
(Date:12/24/2014)... Earlier this year in a June 24 international ... Adult Stem Cell Technology Center, LLC ( ASCTC ) ... unique property of adult tissue stem cells. His ... the Past, Important for the Future,” embodied the essence ... the address at the 4th World Congress on Cell ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... (Nasdaq: BMRN ) today announced that Jean-Jacques Bienaime, ... at the 4th Annual Citi Biotech Day in New York ... parties may access a live audio webcast of the conference ... www.BMRN.com . A replay of the call will be ...
... March 25 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX:SDI), ... sepsis, today announced that the 29th International Symposium ... Belgium from March 24-27, 2009 will feature a ... that will include presentations from six thought leaders ...
... SAN DIEGO, March 25 Aethlon Medical, Inc. ... that supports the advancement of the Aethlon Hemopurifier(R) ... cure rates. The Hemopurifier(R) is a first-in-class medical ... infectious disease through real-time therapeutic filtration of infectious ...
Cached Biology Technology:BioMarin to Present at the 4th Annual Citi Biotech Day 2Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin 2Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 2Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 3Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 4Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 5
(Date:12/15/2014)... 2014 Research and Markets ( ... "Global Facial Recognition Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a ... recognition system measures the overall facial feature of ... and the distance between eyes. Facial recognition is ...
(Date:12/11/2014)... SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ... some long-held beliefs about the condition and the best ways ...
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... Boulders deposited by an ancient glacier that once covered the ... provided more evidence of the extraordinary power and reach of ... Ocean current system that could happen again and continues to ... has found geochemical clues near the summit of Mauna Kea ...
... August 4, 2010 Researchers at the Hebrew University ... the first time a gene associated with susceptibility to ... a significant step toward better understanding and treating of ... problem, afflicting approximately 20% of adults. Some individuals ...
... PITTSBURGHCarnegie Mellon University,s Yoed Rabin has received three ... of Health (NIH) to develop biothermal technology for ... Cryopreservation is the preservation of tissues and organs ... transplantation and regenerative medicine, whereas cryosurgery is the ...
Cached Biology News:Ancient Hawaiian glaciers reveal clues to global climate impacts 2Ancient Hawaiian glaciers reveal clues to global climate impacts 3Hebrew University researchers identify gene related to chronic pain 2Carnegie Mellon's Yoed Rabin receives grants 2
Request Info...
... service provides the premium quality siRNAs you ... siRNAs can be readily ordered online by ... or by providing the sense and antisense ... Validated and Silencer Pre-designed siRNAs, which are ...
... Ambion's custom siRNA service provides the ... gene silencing research. Custom siRNAs can be ... 19-21 base target sequence, or by providing ... check out Ambion's Silencer Validated and Silencer ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Biology Products: